ID Description Gene ratio Bg ratio value valueGene ID Count hsa05161 Hepatitis B 14/54 162/8016 BCL2/JUN/CASP3/CASP8/PRKCA/FOS/IL-6/STAT1/PRKCB/BIRC5/E2F1/E2F2/CDK2/CCNA2 14 hsa04933 AGE-RAGE signaling pathway in diabetic complications 11/54 100/8016 BCL2/JUN/CASP3/PRKCA/VEGFA/MMP2/IL-6/STAT1/F3/CCL2/PRKCB 11 hsa05167 Kaposi sarcoma-associated herpes virus infection 13/54 186/8016 PTGS2/JUN/CASP3/CASP8/VEGFA/FOS/IL-6/STAT1/CXCL2/E2F1/E2F2/CALM1/PPP3CA 13 hsa04657 IL-17 signaling pathway 10/54 94/8016 PTGS2/JUN/CASP3/CASP8/FOS/IL-6/MMP1/CCL2/CXCL2/IL-4 10 hsa05163 Human cytomegalovirus infection 13/54 225/8016 PTGS2/CASP3/CASP8/PRKCA/VEGFA/IL-6/CCL2/PTGER3/PRKCB/E2F1/E2F2/CALM1/PPP3CA 13 hsa04218 Cellular senescence 11/54 160/8016 IL-6/CDK1/CCNB1/CHEK2/E2F1/E2F2/CDK2/CCNA2/CHEK1/CALM1/PPP3CA 11 hsa05170 Human immunodeficiency virus 1 infection 12/54 212/8016 BCL2/JUN/CASP3/CASP8/PRKCA/FOS/CDK1/PRKCB/CCNB1/CHEK1/CALM1/PPP3CA 12 hsa04115 p53 signaling pathway 8/54 72/8016 BCL2/CASP3/CASP8/CDK1/CCNB1/CHEK2/CDK2/CHEK1 8 hsa04020 Calcium signaling pathway 11/54 193/8016 CHRM3/CHRM2/ADRB2/ADRA1D/PRKCA/ERBB2/PTGER3/PRKCB/ERBB3/CALM1/PPP3CA 11 hsa05169 Epstein-Barr virus infection 11/54 201/8016 BCL2/JUN/CASP3/CASP8/IL-6/STAT1/PSMD3/E2F1/E2F2/CDK2/CCNA2 11 hsa05219 Bladder cancer 6/54 41/8016 VEGFA/MMP2/MMP1/ERBB2/E2F1/E2F2 6 hsa05031 Amphetamine addiction 7/54 69/8016 MAOB/JUN/PRKCA/FOS/PRKCB/CALM1/PPP3CA 7 hsa04659 Th17 cell differentiation 8/54 107/8016 RXRA/JUN/FOS/IL-6/STAT1/AHR/IL-4/PPP3CA 8 hsa04668 TNF signaling pathway 8/54 112/8016 PTGS2/JUN/CASP3/CASP8/FOS/IL-6/CCL2/CXCL2 8 hsa05206 MicroRNAs in cancer 12/54 310/8016 PTGS2/BCL2/CASP3/PRKCA/VEGFA/TP63/ERBB2/PRKCB/CYP1B1/E2F1/E2F2/ERBB3 12 hsa01521 EGFR tyrosine kinase inhibitor resistance 7/54 79/8016 BCL2/PRKCA/VEGFA/IL-6/ERBB2/PRKCB/ERBB3 7 hsa04110 Cell cycle 8/54 124/8016 CDK1/CCNB1/CHEK2/E2F1/E2F2/CDK2/CCNA2/CHEK1 8 hsa05166 Human T-cell leukemia virus 1 infection 10/54 219/8016 JUN/FOS/IL-6/CHEK2/E2F1/E2F2/CDK2/CCNA2/CHEK1/PPP3CA 10 hsa05222 Small cell lung cancer 7/54 92/8016 PTGS2/RXRA/BCL2/CASP3/E2F1/E2F2/CDK2 7 hsa05323 Rheumatoid arthritis 7/54 93/8016 JUN/VEGFA/FOS/IL-6/MMP1/CCL2/CXCL2 7 hsa05162 Measles 8/54 138/8016 BCL2/JUN/CASP3/CASP8/FOS/IL-6/STAT1/CDK2 8 hsa01522 Endocrine resistance 7/54 98/8016 BCL2/JUN/FOS/MMP2/ERBB2/E2F1/E2F2 7 hsa05223 Non-small cell lung cancer 6/54 66/8016 RXRA/PRKCA/ERBB2/PRKCB/E2F1/E2F2 6 hsa04625 C-type lectin receptor signaling pathway 7/54 104/8016 PTGS2/JUN/CASP8/IL-6/STAT1/CALM1/PPP3CA 7 hsa01524 Platinum drug resistance 6/54 73/8016 BCL2/CASP3/CASP8/ERBB2/BIRC5/TOP2A 6 hsa05140 Leishmaniasis 6/54 77/8016 PTGS2/JUN/FOS/STAT1/PRKCB/IL-4 6 hsa04970 Salivary secretion 6/54 90/8016 0.000215397 CHRM3/ADRB2/ADRA1D/PRKCA/PRKCB/CALM1 6 hsa04370 VEGF signaling pathway 5/54 59/8016 0.000319433 0.000129578 PTGS2/PRKCA/VEGFA/PRKCB/PPP3CA 5 hsa04215 Apoptosis—multiple species 4/54 32/8016 0.000398847 0.000161792 BCL2/CASP3/CASP8/BIRC5 4 hsa05205 Proteoglycans in cancer 8/54 204/8016 0.000398847 0.000161792 CASP3/PRKCA/VEGFA/MMP2/ERBB2/CAV1/PRKCB/ERBB3 8 hsa04921 Oxytocin signaling pathway 7/54 153/8016 0.000444038 0.000180123 PTGS2/JUN/PRKCA/FOS/PRKCB/CALM1/PPP3CA 7 hsa05160 Hepatitis C 7/54 155/8016 0.00046711 0.000189483 RXRA/CASP3/CASP8/STAT1/E2F1/E2F2/CDK2 7 hsa04066 HIF-1 signaling pathway 6/54 109/8016 0.000519791 0.000210852 BCL2/PRKCA/VEGFA/IL-6/ERBB2/PRKCB 6 hsa04725 Cholinergic synapse 6/54 112/8016 0.000586899 0.000238075 CHRM3/CHRM2/BCL2/PRKCA/FOS/PRKCB 6 hsa04151 PI3K-Akt signaling pathway 10/54 354/8016 0.000104478 0.000611944 0.000248234 RXRA/CHRM2/BCL2/PRKCA/VEGFA/IL-6/ERBB2/ERBB3/CDK2/IL-4 10 hsa04726 Serotonergic synapse 6/54 115/8016 0.000112728 0.000641922 0.000260395 PTGS1/PTGS2/MAOB/CASP3/PRKCA/PRKCB 6 hsa05164 Influenza A 7/54 170/8016 0.000130414 0.000722567 0.000293108 CASP3/CASP8/PRKCA/IL-6/STAT1/CCL2/PRKCB 7 hsa04010 MAPK signaling pathway 9/54 295/8016 0.000135506 0.00072873 0.000295608 JUN/CASP3/PRKCA/VEGFA/FOS/ERBB2/PRKCB/ERBB3/PPP3CA 9 hsa05214 Glioma 5/54 75/8016 0.000138636 0.00072873 0.000295608 PRKCA/PRKCB/E2F1/E2F2/CALM1 5 hsa05133 Pertussis 5/54 76/8016 0.000147646 0.000738228 0.000299461 JUN/CASP3/FOS/IL-6/CALM1 5 hsa05212 Pancreatic cancer 5/54 76/8016 0.000147646 0.000738228 0.000299461 VEGFA/STAT1/ERBB2/E2F1/E2F2 5 hsa05152 Tuberculosis 7/54 180/8016 0.000186086 0.000908277 0.000368441 BCL2/CASP3/CASP8/IL-6/STAT1/CALM1/PPP3CA 7 hsa04621 NOD-like receptor signaling pathway 7/54 181/8016 0.000192575 0.00091809 0.000372422 BCL2/JUN/CASP8/IL-6/STAT1/CCL2/CXCL2 7 hsa04114 Oocyte meiosis 6/54 128/8016 0.000203229 0.000946864 0.000384094 PGR/CDK1/CCNB1/CDK2/CALM1/PPP3CA 6 hsa04926 Relaxin signaling pathway 6/54 129/8016 0.000212049 0.000966002 0.000391857 JUN/PRKCA/VEGFA/FOS/MMP2/MMP1 6 hsa04728 Dopaminergic synapse 6/54 132/8016 0.000240337 0.001071065 0.000434476 MAOB/PRKCA/FOS/PRKCB/CALM1/PPP3CA 6 hsa04012 ErbB signaling pathway 5/54 85/8016 0.000250398 0.001092162 0.000443034 JUN/PRKCA/ERBB2/PRKCB/ERBB3 5 hsa05210 Colorectal cancer 5/54 86/8016 0.000264505 0.001129656 0.000458243 BCL2/JUN/CASP3/FOS/BIRC5 5 hsa04210 Apoptosis 6/54 136/8016 0.000282596 0.001182288 0.000479593 BCL2/JUN/CASP3/CASP8/FOS/BIRC5 6 hsa04915 Estrogen signaling pathway 6/54 138/8016 0.00030581 0.001253821 0.00050861 PGR/BCL2/JUN/FOS/MMP2/CALM1 6 hsa04510 Focal adhesion 7/54 199/8016 0.000344429 0.001384471 0.000561608 BCL2/JUN/PRKCA/VEGFA/ERBB2/CAV1/PRKCB 7 hsa04658 Th1 and Th2 cell differentiation 5/54 92/8016 0.000362266 0.001415656 0.000574258 JUN/FOS/STAT1/IL-4/PPP3CA 5 hsa05203 Viral carcinogenesis 7/54 201/8016 0.000365999 0.001415656 0.000574258 JUN/CASP3/CASP8/CDK1/CDK2/CCNA2/CHEK1 7 hsa04912 GnRH signaling pathway 5/54 93/8016 0.000380906 0.001446032 0.000586581 JUN/PRKCA/MMP2/PRKCB/CALM1 5 hsa05224 Breast cancer 6/54 147/8016 0.000429481 0.001600791 0.000649358 PGR/JUN/FOS/ERBB2/E2F1/E2F2 6 hsa05226 Gastric cancer 6/54 149/8016 0.000461636 0.001664529 0.000675213 RXRA/BCL2/ERBB2/E2F1/E2F2/CDK2 6 hsa05215 Prostate cancer 5/54 97/8016 0.00046282 0.001664529 0.000675213 BCL2/ERBB2/E2F1/E2F2/CDK2 5 hsa04923 Regulation of lipolysis in adipocytes 4/54 55/8016 0.000486421 0.001719247 0.000697409 PTGS1/PTGS2/ADRB2/PTGER3 4 hsa04914 Progesterone-mediated oocyte maturation 5/54 99/8016 0.000508446 0.001766634 0.000716632 PGR/CDK1/CCNB1/CDK2/CCNA2 5 hsa05134 Legionellosis 4/54 57/8016 0.000557794 0.001905798 0.000773083 CASP3/CASP8/IL-6/CXCL2 4 hsa05142 Chagas disease (American trypanosomiasis) 5/54 102/8016 0.00058314 0.001928126 0.000782141 JUN/CASP8/FOS/IL-6/CCL2 5 hsa05146 Amoebiasis 5/54 102/8016 0.00058314 0.001928126 0.000782141 CASP3/PRKCA/IL-6/PRKCB/CXCL2 5 hsa04620 Toll-like receptor signaling pathway 5/54 104/8016 0.000637332 0.002073857 0.000841257 JUN/CASP8/FOS/IL-6/STAT1 5 hsa04928 Parathyroid hormone synthesis, secretion, and action 5/54 106/8016 0.000695221 0.00222688 0.00090333 RXRA/BCL2/PRKCA/FOS/PRKCB 5 hsa05321 Inflammatory bowel disease (IBD) 4/54 65/8016 0.000918763 0.002897638 0.001175422 JUN/IL-6/STAT1/IL-4 4 hsa04720 Long-term potentiation 4/54 67/8016 0.001029849 0.003198774 0.001297577 PRKCA/PRKCB/CALM1/PPP3CA 4 hsa05165 Human papillomavirus infection 8/54 330/8016 0.001505195 0.004605448 0.001868192 PTGS2/CASP3/CASP8/VEGFA/STAT1/E2F1/CDK2/CCNA2 8 hsa04971 Gastric acid secretion 4/54 75/8016 0.001569477 0.00473151 0.001919329 CHRM3/PRKCA/PRKCB/CALM1 4 hsa04380 Osteoclast differentiation 5/54 128/8016 0.001623043 0.004822084 0.00195607 JUN/PPARG/FOS/STAT1/PPP3CA 5 hsa04960 Aldosterone-regulated sodium reabsorption 3/54 37/8016 0.00190982 0.005514268 0.002236853 NR3C2/PRKCA/PRKCB 3 hsa05143 African trypanosomiasis 3/54 37/8016 0.00190982 0.005514268 0.002236853 PRKCA/IL-6/PRKCB 3 hsa04662 B cell receptor signaling pathway 4/54 82/8016 0.002181418 0.006210983 0.002519474 JUN/FOS/PRKCB/PPP3CA 4 hsa05235 PD-L1 expression and PD-1 checkpoint pathway in cancer 4/54 89/8016 0.002941331 0.008259901 0.003350615 JUN/FOS/STAT1/PPP3CA 4 hsa05132 Salmonella infection 6/54 214/8016 0.002993412 0.008292561 0.003363863 BCL2/JUN/CASP3/CASP8/FOS/IL-6 6 hsa04024 cAMP signaling pathway 6/54 216/8016 0.003134975 0.008396427 0.003405996 CHRM2/ADRB2/JUN/FOS/PTGER3/CALM1 6 hsa04261 Adrenergic signaling in cardiomyocytes 5/54 149/8016 0.00315378 0.008396427 0.003405996 ADRB2/ADRA1D/BCL2/PRKCA/CALM1 5 hsa04932 Nonalcoholic fatty liver disease (NAFLD) 5/54 149/8016 0.00315378 0.008396427 0.003405996 RXRA/JUN/CASP3/CASP8/IL-6 5 hsa04713 Circadian entrainment 4/54 97/8016 0.004011834 0.010543923 0.004277124 PRKCA/FOS/PRKCB/CALM1 4 hsa05231 Choline metabolism in cancer 4/54 98/8016 0.004161902 0.010799873 0.00438095 JUN/PRKCA/FOS/PRKCB 4 hsa04064 NF-kappa B signaling pathway 4/54 102/8016 0.004800227 0.012300582 0.00498971 PTGS2/BCL2/PRKCB/CXCL2 4 hsa04022 cGMP-PKG signaling pathway 5/54 167/8016 0.00512959 0.012857065 0.005215446 ADRB2/ADRA1D/ADRA2A/CALM1/PPP3CA 5 hsa04660 T cell receptor signaling pathway 4/54 104/8016 0.005142826 0.012857065 0.005215446 JUN/FOS/IL-4/PPP3CA 4 hsa05014 Amyotrophic lateral sclerosis (ALS) 3/54 57/8016 0.006541874 0.01615764 0.006554319 BCL2/CASP3/PPP3CA 3 hsa05145 Toxoplasmosis 4/54 112/8016 0.006677299 0.016295788 0.006610358 BCL2/CASP3/CASP8/STAT1 4 hsa05202 Transcriptional misregulation in cancer 5/54 186/8016 0.008035734 0.0193803 0.007861585 RXRA/PPARG/IL-6/RUNX1T1/CCNA2 5 hsa04919 Thyroid hormone signaling pathway 4/54 119/8016 0.008247201 0.01943306 0.007882987 RXRA/PRKCA/STAT1/PRKCB 4 hsa04935 Growth hormone synthesis, secretion, and action 4/54 119/8016 0.008247201 0.01943306 0.007882987 PRKCA/FOS/STAT1/PRKCB 4 hsa04152 AMPK signaling pathway 4/54 120/8016 0.0084896 0.019554697 0.007932329 PPARG/ACACA/SLC2A4/CCNA2 4 hsa05135 Yersinia infection 4/54 120/8016 0.0084896 0.019554697 0.007932329 JUN/FOS/IL-6/CCL2 4 hsa04924 Renin secretion 3/54 69/8016 0.011069325 0.025102948 0.010182967 ADRB2/CALM1/PPP3CA 3 hsa05130 Pathogenic Escherichia coli infection 5/54 202/8016 0.011245951 0.025102948 0.010182967 JUN/CASP3/CASP8/FOS/IL-6 5 hsa04068 FoxO signaling pathway 4/54 131/8016 0.011469853 0.025102948 0.010182967 IL-6/CCNB1/SLC2A4/CDK2 4 hsa04650 Natural killer cell-mediated cytotoxicity 4/54 131/8016 0.011469853 0.025102948 0.010182967 CASP3/PRKCA/PRKCB/PPP3CA 4 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3/54 70/8016 0.01151062 0.025102948 0.010182967 JUN/CASP3/CXCL2 3 hsa04270 Vascular smooth muscle contraction 4/54 132/8016 0.011770178 0.025398806 0.010302982 ADRA1D/PRKCA/PRKCB/CALM1 4 hsa03320 PPAR signaling pathway 3/54 76/8016 0.014370984 0.030688039 0.01244855 RXRA/PPARG/MMP1 3 hsa05204 Chemical carcinogenesis 3/54 82/8016 0.017600508 0.03719695 0.015088878 PTGS2/ADH1C/CYP1B1 3 hsa04911 Insulin secretion 3/54 86/8016 0.019960958 0.041668682 0.016902829 CHRM3/PRKCA/PRKCB 3 hsa04934 Cushing syndrome 4/54 155/8016 0.020122924 0.041668682 0.016902829 AHR/E2F1/E2F2/CDK2 4 hsa04540 Gap junction 3/54 88/8016 0.021203742 0.043467672 0.017632586 PRKCA/CDK1/PRKCB 3 hsa04310 Wnt signaling pathway 4/54 160/8016 0.022321682 0.045306384 0.018378456 JUN/PRKCA/PRKCB/PPP3CA 4 hsa04630 JAK-STAT signaling pathway 4/54 162/8016 0.023240916 0.046709685 0.018947703 BCL2/IL-6/STAT1/IL-4 4 hsa00350 Tyrosine metabolism 2/54 36/8016 0.024244872 0.048254357 0.019574296 ADH1C/MAOB 2